TOP TIERMARKET NEWSWIRE
News & sentiment

COSCIENS BIOPHARMA I (CSCIF) — News & AI sentiment

COSCIENS BIOPHARMA I (CSCIF) news roundup. 1 story in the last 24 hours, 3 in the past week, 3 over 30 days. Average 24-hour sentiment is 24/100 — bearish-leaning (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 24/100
7d stories
3
avg sentiment 49.3/100
30d stories
3
avg sentiment 49.3/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

CSCIF news in the last 24 hours, 7 days, 30 days and 90 days

How much CSCIF coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCSCIF storiesAvg AI sentimentRead
Last 24 hours124/100CSCIF headlines →
Last 7 days349.3/100CSCIF headlines →
Last 30 days349.3/100CSCIF headlines →
Last 90 days848.6/100CSCIF headlines →

Latest stories on CSCIF

5h ago
COSCIENS ACQUIRES NUALTIS CORP.
GlobeNewswire62 · neutralm&a
6d ago
COSCIENS ACQUIRES NUALTIS CORP.
Business Insider62 · neutralm&a
6d ago
COSCIENS Biopharma Inc. Reports Q2 2026 Results
Business Insider50 · neutralearnings
Aug 11
Aug 11
Jul 30
Jul 3
Jun 23
Jun 18
May 20
Open CSCIF in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →